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The neuropeptide oxytocin (OT) and its receptor (OXTR) have been predicted to be
involved in the regulation of social functioning in autism spectrum disorders (ASD).
Objective of the study was to investigate serum OT levels and the OXTR rs2254298
polymorphism in Chinese Han children and adolescents with ASD as well as to identify
their social deficits relevant to the oxytocinergic system. We tested serum OT levels using
ELISA in 55 ASD subjects and 110 typically developing (TD) controls as well as genotyped
the OXTR rs2254298 polymorphism using PCR-RFLP in 100 ASD subjects and 232
TD controls. Autistic symptoms were assessed by the Autism Behavior Checklist (ABC)
and the Childhood Autism Rating Scale (CARS). There were no significant associations
between OXTR rs2254298 polymorphism and ASD, serum OT levels and age, as well
as serum OT levels and intelligent quotient (IQ) in both ASD and TD groups. However,
ASD subjects exhibited elevated serum OT levels compared to TD controls and positive
correlations between serumOT levels and “adaptation to change score” in the CARS and
CARS total scores. Moreover, in the ASD group, significant relationships were revealed
between the single-nucleotide polymorphism (SNP) rs2254298 and serum OT levels,
the category “stereotypes and object use” in the ABC and the category “adaptation to
change” in the CARS. These findings indicated that individuals with ASD may exhibit
a dysregulation in OT on the basis of changes in OXTR gene expression as well as
environmentally induced alterations of the oxytocinergic system to determine their social
deficits.
Keywords: autism spectrum disorders, oxytocin, oxytocin receptor gene, rs2254298, social deficits, children and
adolescents
Yang et al. Oxytocinergic System and Social Deficits in ASD
INTRODUCTION
Autism spectrum disorders (ASD) are a set of complex
neurodevelopmental disorders characterized by deficits in social
interaction and communication as well as restricted, repetitive
behaviors (American Psychiatric Association, 2013). A recent
epidemiological survey estimated the prevalence of ASD to be
one in 68 children, with amale: female ratio of 4.5: 1 (CDC, 2014).
The etiology of ASD likely includes both genetic heritability
and environmental risk factors (Hallmayer et al., 2011; Ronald
and Hoekstra, 2011), and twin studies have demonstrated an
estimated heritability of 70–90% (Freitag, 2011; Robinson et al.,
2012). ASD result in negative effects on physical health and
quality of life among the ASD population as well as heavy burdens
to their families and society.
A wealth of literature indicates intense interest in the function
of oxytocin (OT) in affiliation and social behavior in both animals
and humans (Carter, 1998; Donaldson and Young, 2008; Insel,
2010). Some studies have also suggested a potential association
between a primary dysfunction of the central OT system and
core symptoms of social deficits in ASD (Insel et al., 1999; Lukas
and Neumann, 2013). Because previous work has implied the
important role of oxytocin receptor (OXTR) in the modulation
of OT activities and the OT-OXTR signaling may be involved in
ASD pathophysiology (Yamasue, 2013), theOXTR gene is notable
as a potential candidate gene for ASD. These findings have
attracted researchers to investigate whether genetic variation in
human OXTR gene is associated with social deficits in ASD.
OT is a nonapeptide with a highly conserved structure
and is mainly synthesized in magnocellular neurons in the
paraventricular and supraoptic nuclei of the mammalian
hypothalamus. OT affects peripheral tissues and central brain
regions, including the central OXTR network. Centrally
projecting neuropeptidergic neurons target regions that regulate
stress coping, moods, and social behaviors (Taurines et al., 2014).
In addition, OT has been reported to be involved in attachment,
pair bonding, sexual reproduction, maternal behavior, stress
response, social memory, emotional cognition, and social
interaction (Insel and Fernald, 2004; Kosfeld et al., 2005; Lee
et al., 2009). Metabolic abnormalities of OT (Green et al., 2001)
have exhibited a significant association with impairment in social
interaction and communication in ASD individuals.
These outcomes indicate that OT may play a role in the
etiology of ASD, especially in the social impairment domain.
Several exogenous OT treatments have managed to normalize
impaired social functioning among individuals with ASD. Adult
ASD patients exhibited reduced repetitive behaviors (Hollander
et al., 2003) and enhanced affective speech comprehension
(Hollander et al., 2007) after intravenous OT infusion. Improved
emotional recognition from eye regions in ASD boys was
reported after intranasal OT administration (Guastella et al.,
2010). Moreover, increased cooperation in simulated ball games,
feelings of trust with teammates and time spent gazing at the
eye regions of unfamiliar faces (Andari et al., 2010), as well as
improvements in social cognition and quality of life (Anagnostou
et al., 2012) have been reported in adult ASD patients after
OT nasal sprays. These findings provide evidence that OT may
have the potential to improve human social cognition and
behavior and to partially restore the damaged social cognitive
neurological functions (Meyer-Lindenberg et al., 2011; Striepens
et al., 2011). Nevertheless, recent double-blind, randomized,
placebo-controlled studies in ASD individuals did not disclose
significant clinical efficacies of intranasal OT on social cognition
or behavior. For example, compared to the placebo group, Dadds
et al. (2014) demonstrated that the intranasal OT treatment for
male youths with ASD did not bring significant improvements
on social interaction skills, emotion recognition, or general
behavioral adjustment. Guastella et al. (2015) also did not find
the efficacy of OT nasal spray for youth with ASD on social
responsiveness and social cognition. Moreover, Althaus et al.
(2015) detected no significant treatment effects of OT nasal spray
for male adults on empathic arousal responses to affective social
pictures. Therefore, it is essential to discover the real relationship
between the oxytocinergic system and ASD.
Experiments have been designed to measure plasma OT levels
in individuals with ASD to compute pertinent correlations.
Relative to typically developing (TD) controls, several groups
have reported lower plasma OT levels in individuals with ASD
(Modahl et al., 1998; Green et al., 2001; Al-Ayadhi, 2005; Andari
et al., 2010). However, there are also studies demonstrating
elevated plasma OT levels in ASD participants (Jansen et al.,
2006; Jacobson et al., 2014). Furthermore, a third group of studies
reported no differences in plasma OT levels between ASD cases
and unaffected controls (Miller et al., 2013; Parker et al., 2014;
Taurines et al., 2014). There still remains questions that whether
low or high plasma OT levels act as a biomarker of ASD and/or
social deficits.
The OXTR gene is located on chromosome 3p25, spans
17 kb and includes four exons and three introns (Inoue
et al., 1994). It encodes a member of the class I family of
G protein-coupled receptors, which are characterized by seven
transmembrane domains. Oxytocin receptors are concentrated
in brain regions involved in social behavior, including the
olfactory bulbs, pyriform cortex, amygdala, and lateral septum
(Ferguson et al., 2000). Genome-wide linkage studies (McCauley
et al., 2005; Lauritsen et al., 2006) have suggested that the
OXTR gene is a plausible candidate gene for ASD. In addition,
polymorphisms in the OXTR gene may affect human social
cognition and attachment (Chen et al., 2011; Wu et al., 2012)
and abnormalities in the OXTR gene have been proposed to
cause social disorders in individuals with ASD (Choleris et al.,
2007; Lerer et al., 2008). The association between OXTR gene
polymorphisms and the etiology of ASD has drawn massive
attention. At present, a single-nucleotide polymorphism (SNP) in
the third intron, rs2254298, has been identified as a particularly
promising candidate to explain differences in oxytocinergic
functioning (Meyer-Lindenberg et al., 2011), especially in social
functioning (Costa et al., 2009; Chen et al., 2011; Thompson
et al., 2011; Wu et al., 2012). Comparative genetics imply that a
mutation replacing guanine (G) by adenine (A) of OXTR SNP
rs2254298 has occurred at some point during human evolution.
In European populations, the vast majority of individuals are
homozygous for the G allele, but in Asian populations, the
frequency of GG genotype is around just 40–50% compared
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with the frequencies of AA and AG genotypes (Chelala et al.,
2009). Reasons for the selection of SNP rs2254298 in our study
were on the basis of its special function and the inconsistent
conclusions of aforetime studies involving ethnically distinct
study populations: a Chinese Han population (Wu et al., 2005),
a Caucasian population in the United States (Jacob et al., 2007),
Swiss (Nyffeler et al., 2014), and northern European populations
(Di Napoli et al., 2014), a Japanese population (Liu et al., 2010), an
Israeli population (Lerer et al., 2008) and a German population
(Wermter et al., 2010). For instance, studies on Chinese (Wu
et al., 2005) and Japanese (Liu et al., 2010) populations discovered
that the “A” allele of rs2254298 was associated with ASD.
However, Jacob et al. (2007) found the “G” allele of rs2254298
as a risk allele in Caucasian ASD population. These results
need further studies to clarify the role of OXTR rs2254298
polymorphism in ASD.
Although recent evidence supporting the essential role of OT
and the OXTR gene in social functioning in ASD individuals has
been reported, no consensus has been made on the associations
among OT levels, the OXTR SNP rs2254298 and ASD. In order
to clarify whether significant differences of serum OT levels and
OXTR rs2254298 polymorphismwould exhibit between ASD and
TD groups, as well as seek out the interaction of serum OT
levels and OXTR rs2254298 polymorphism and their impacts
on social deficits of ASD subjects in Chinese Han children
and adolescents, the present case-control study tested serum
OT levels using ELISA, detected the presence of the OXTR
rs2254298 polymorphism using PCR-RFLP and measured the
ASD social phenotypes using the ABC and CARS scales in ASD
subjects and TD controls of both genders. We analyzed the
differences of serum OT levels between the ASD and TD groups,
the correlations between serum OT levels and age, intelligent
quotient (IQ), the ABC scores and the CARS scores. Moreover,
the association between the OXTR rs2254298 polymorphism
and ASD, as well as the relationships between OXTR SNP
rs2254298 genotypes and serum OT levels, the ABC scores and
the CARS scores were also analyzed. Finally, we hypothesized
that Chinese Han children and adolescents with ASDmay exhibit
a dysregulation in OT on the basis of changes in OXTR gene
expression as well as environmentally induced alterations of the
oxytocinergic system to determine their social deficits.
MATERIALS AND METHODS
Participants
The study was approved by the Tianjin Medical University
Institutional Review Board and written informed consent was
obtained from school principals, parents and/or caregivers after
a clear elaboration of detailed information. We recruited Chinese
Han children and adolescents with ASD from the local special
education schools and Chinese Han TD controls from the local
mainstream schools in Tianjin. Serum OT levels were measured
by ELISA in 55 ASD subjects (43 males and 12 females) and
110 age- and gender-matched TD controls (86 males and 24
females) between 2 and 17 years of age. The OXTR rs2254298
polymorphism was genotyped by PCR-RFLP in 100 ASD subjects
(80 males and 20 females) and 232 age- and gender-matched
TD controls (186 males and 46 females) between 2 and 18
years of age. Participants for ELISA (ASD group, n = 55; TD
group, n = 110) were a subset of participants for PCR-RFLP
(ASD group, n = 100; TD group, n = 232). ASD subjects
were diagnosed by qualified and experienced psychologists,
psychiatrists or neurologists according to the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV) criteria (American Psychiatric Association, 1996) in the
major hospitals of Tianjin and Beijing, which was conformed
with the Childhood Autism Rating Scale (CARS) (Schopler et al.,
1980) by clinical pediatric psychiatrists in Tianjin. A CARS total
score of ≥30 is the cutoff for distinguishing children “at risk”
for autism from pervasive developmental disorder-not otherwise
specified (PDD-NOS) (Schopler et al., 1988; Chlebowski et al.,
2010), and a CARS total score of ≥25.5 is indicative of ASD
(Chlebowski et al., 2010). Participant characteristics are reported
in Table 1. The Autism Behavior Checklist (ABC) was also
administered for the assessment of their autistic symptoms
(Rellini et al., 2004). Moreover, intelligent quotient (IQ) was
determined using the Chinese Binet Scale (Binet) (Wu, 1982)
by clinical pediatric psychologists in Tianjin. ASD subjects
were included with a full-scale IQ of ≥30 and TD controls
were included with an IQ in the average range. Moreover, 6
ASD subjects for ELISA and 9 ASD subjects for PCR-RFLP
had an IQ of >70. In the present study, none of the ASD
subjects fulfilled a DSM-IV diagnosis (American Psychiatric
Association, 1996) of any mental disorders (schizophrenia,
attention deficit/hyperactivity disorder, depressive disorder, and
bipolar disorder), as well as suffered from epileptic seizures and
fragile X syndrome on the basis of medical history reported by
parents. TD controls were required to be free of psychiatric,
neurological or physical disorders in the present or past on the
basis of medical history reported by parents and with a score
of <7 on the Clancy Autism Behavior Scale (CABS) (Clancy
et al., 1969). To ensure the robustness of the experiments, none
of the participants in any group were taking special drugs, such
as psychotropic or immune-altering medications.
Assessment of Autistic Symptoms
Autism Behavior Checklist (ABC)
The Autism Behavior Checklist (ABC) is a behavior checklist
that consists of 57 items in 5 categories: “sensory”, “relating”,
“stereotypes and object use”, “language”, and “social and self-
help”. Each item corresponds to a single score referring to a single
symptomatological area (Rellini et al., 2004). The scale utilizes
an observer’s rating of a series of typical autistic behaviors in a
certain subject and provides advice for educational intervention.
Childhood Autism Rating Scale (CARS)
The Childhood Autism Rating Scale (CARS) is a 15-item
behavior rating scale that includes 14 domains plus one category
of general impressions that are rated on a four-point scale (1
= appropriate for age; 2 = mildly abnormal; 3 = moderately
abnormal; 4 = severely abnormal) according to interaction
and observation. The 15 items are as follows: “relating to
people”, “imitative behavior”, “emotional response”, “body use”,
“object use”, “adaptation to change”, “visual response”, “listening
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TABLE 1 | Participant characteristics.
Participants Total (n) Sex (n) Age (year) CARS total score Full-scale IQ
Male Female
ELISA FOR OT
ASD group 55 43 12 7.73 ± 0.56 32.56 ± 0.48 59.65 ± 1.76
Autism 45 34 11 7.96 ± 0.65 33.56 ± 0.47 56.27 ± 1.59
Severe autism 9 7 2 11.78 ± 1.33 38.78 ± 0.40 49.11 ± 3.85
Mild/moderate autism 36 27 9 7.00 ± 0.66 32.25 ± 0.30 58.06 ± 1.63
PDD-NOS 10 9 1 6.70 ± 0.99 28.10 ± 0.31 74.90 ± 3.85
TD group 110 86 24 7.75 ± 0.24 101.70 ± 0.71
PCR-RFLP FOR OXTR
ASD group 100 80 20 8.52 ± 0.42 33.30 ± 0.44 56.25 ± 1.49
Autism 83 65 18 8.94 ± 0.46 34.41 ± 0.44 52.25 ± 1.25
Severe autism 25 20 5 10.28 ± 0.82 39.88 ± 0.43 43.08 ± 1.83
Mild/moderate autism 58 45 13 8.36 ± 0.55 32.05 ± 0.21 56.21 ± 1.30
PDD-NOS 17 15 2 6.47 ± 0.76 27.88 ± 0.27 75.76 ± 3.61
TD group 232 186 46 8.42 ± 0.25 102.06 ± 0.50
Participants for ELISA (ASD group, n = 55; TD group, n = 110) were a subset of participants for PCR-RFLP (ASD group, n = 100; TD group, n = 232). The values are expressed in
mean ± SEM. ASD, autism spectrum disorders; CARS, Childhood Autism Rating Scale; ELISA, enzyme-linked immunosorbent assay; IQ, intelligent quotient; n, number; OT, oxytocin;
OXTR, oxytocin receptor; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphism, PDD-NOS, pervasive developmental disorder-not otherwise specified, TD,
typically developing.
response”, “perceptive response”, “fear or anxiety”, “verbal
communication”, “non-verbal communication”, “activity level”,
“level and consistency of intellective relations”, and “general
impressions” (Rellini et al., 2004). The CARS is widely used by
psychiatrists to identify children with autism and as a further
measurement of the severity of this disease. Total scores can
range from a low of 15 to a high of 60; scores of less than 30
indicate that the individual is in the non-autistic range, scores
between 30 and 36.5 indicate mild/moderate autism, and scores
from 37 to 60 indicate severe autism (Schopler et al., 1988).
Sample Collection
Participants were previously informed to fast in the morning
before sampling to avoid the influence of food and/or drink.
Five milliliters of venous blood were collected from each
participant’s antecubital region by trained and qualified nurses
between 8:00 and 9:30 a.m. in pro-coagulation tubes with yellow
caps (Becton, Dickinson and Company). The tubes were gently
inverted five times immediately and left undisturbed at room
temperature for 30 min. Then, they were kept on ice until
centrifuging at 1,731 × g for 10min at 4◦C. Serum was isolated
and divided into 1-ml aliquots and immediately stored at−80◦C
until assay.
DNA samples were obtained by an experienced technician
by taking a sterile swab and rubbing it against the inside of
participants’ cheeks and placing it into a labeled sterile 2-ml
Falcon tube.
DNA Extraction
DNA was extracted from the swabs according to the
manufacturer’s protocol for the Swab Gen DNA Kit (CW0530,
CWBIO, Beijing, China). The DNA solution for the current
experiment was then stored at 4◦C, and the redundant stock
was stored at −20◦C. The concentration of each DNA sample
was determined using a NanoDrop ND-2000 spectrophotometer
(Thermo Scientific).
Oxytocin Enzyme-Linked Immunosorbent
Assay (ELISA)
Serum sample extraction procedures were previously carried
out to decrease the potential cross-reacting molecules. A
1:1 mixture of serum sample and 0.1% trifluoroacetic acid
in water (TFA-H2O) was centrifuged at 17,000 × g for
15min at 4◦C. Supernatants were applied to the Sep-Pak C18
columns (Waters Corporation Milford, Massachusetts USA)
and eluted off with a solution (acetonitrile/0.1% TFA-H2O
ratio 60:40). Samples was evaporated at 4◦C and stored at
−20◦C until reconstitution. Serum OT levels were measured
using commercially available ELISA Kits (O30152-09, Beijing
Biotopped Science & Technology CO., Ltd., China), all steps in
the manufacturer’s instructions were followed, and results were
read under 450 nm wavelength on a Power Wave-I microplate
spectrophotometer (Sunrise-Basic BioTek, Tecan). All assays
were performed in duplicate. Standard curves and concentrations
were computed by Excel. The assay range was from 2 pg/ml to 600
pg/ml. The intra-assay coefficient of variation was 6.9%, and the
inter-assay coefficient of variation was 11.8%.
Genotyping
The OXTR SNP rs2254298 was amplified by using polymerase
chain reaction-restriction fragment length polymorphism (PCR-
RFLP) analysis. The primer sequences were as follows: 5′-TGA
AAG CAG AGG TTG TGT GGA CAG G-3′ and 5′-AAC GCC
CAC CCC AGT TTC TTC-3′ (Wu et al., 2005). PCR was
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performed on a C1000 Thermal Cycler (Bio-Rad, Hercules, CA,
USA) in a 20-µl volume consisting of 0.1 µl Taq (Takara, Code.
#DR001A), 2 µl 10 × PCR buffer (with Mg2+), 1.6 µl dNTP
Mixture (2.5mM), 1 µl each of the forward and reverse primers
(10 µM/L), 3 µl genomic DNA, and 11.3 µl ddH2O. The PCR
process included an initial denaturation step at 95◦C for 5min;
35 cycles of denaturation at 95◦C for 30 s, annealing at 64.5◦C
for 30 s and extension at 72◦C for 1min; followed by a final
extension for 7min at 72◦C. PCR products that were 307 bp
long were visualized on a 2% agarose gel after electrophoresis.
After the PCR products were digested at 65◦C for 20min with
0.5 µl of the restriction enzyme BsrI (New England Biolabs, Cat.
#R0527), the samples were run at 80 V for 90min on an 8%
polyacrylamide gel (acrylamide/bis-acrylamide ratio 19:1) and
were visualized to distinguish the G allele (bands of 164, 101, 34,
and 8 bp) from the A allele (bands of 164, 135, and 8 bp). To
ensure the accuracy of the RFLP profiles, gene sequencing was
performed by Genewiz Inc, and the sequencing results agreed
with the PCR-RFLP results.
Statistical Analysis
The results were analyzed using SPSS17.0 software (IBM
Corporation New York, USA) and SAS version 9.3.2 (SAS
Institute Inc, Cary, NC). Kolmogorov-Smirnov test was
performed to determine the normal distribution of the data.
Levene’s test was utilized to determine the homogeneity of
variance. Differences in serum OT levels between two groups
were examined with a Mann-Whitney U test and spearman
rank-order correlations (including spearman partial correlation)
were used to evaluate strength of associations. The Hardy-
Weinberg equilibrium for the genotype frequency distributions
of rs2254298 was assessed using a χ2 goodness-of-fit test. A
χ
2-test was also used in analyzing the genotype and allele
frequencies, with a significance level of α = 0.05. A one-way
analysis of covariance (ANCOVA) with sex, age, and IQ as
covariates was applied for comparisons of ABC scores among
three OXTR SNP rs2254298 genotypes. Kruskal-Wallis H tests
were utilized for comparisons of serum OT levels and CARS
total scores among three OXTR SNP rs2254298 genotypes. A
ordinal polytomous logistic regression analysis was performed
to discover the differences of the scores of each item in the
CARS among three OXTR SNP rs2254298 genotypes (while
adjusting for sex, age, and IQ). Odds ratios (ORs) were expressed
with 95% confidence intervals (95% CI). Post-hoc Bonferroni
correction for multiple comparisons was performed. A p < 0.05
was considered significant.
RESULTS
Serum Oxytocin (OT) Levels
A Mann-Whitney U test was used to assess the differences
between ASD subjects and TD controls. Serum OT levels was
significantly higher in the ASD group compared with the TD
group (Z = −2.178, p = 0.029). However, gender had no
significant effect on serum OT levels in any comparison, between
the two groups (males Z = −1.694, p = 0.090; females Z =
−1.309, p = 0.191) and between males and females within the
ASD group (Z = −1.100, p = 0.271) and within the TD group
(Z =−1.230, p= 0.219) (Figure 1). Correlations between serum
OT levels and age, as well as IQ are presented in Table 2 with
unadjusted and adjusted spearman rank-order correlations. The
positive correlations between serum OT levels and age of all ASD
subjects, as well as ASD males vanished after Spearman partial
correlation. No associations were found between serumOT levels
and IQ with both analyses in ASD and TD groups.
Oxytocin Receptor (OXTR) Gene rs2254298
Polymorphism
The distribution of the OXTR SNP rs2254298 genotypes was
consistent with the Hardy-Weinberg equilibrium for both groups
(χ2 = 0.007, df = 2, p = 0.996 in ASD subjects; χ2 = 0.292, df
= 2, p = 0.864 in TD controls). No statistical differences were
found from the genotypic and allelic frequencies of the OXTR
SNP rs2254298 in ASD subjects and TD controls (p > 0.05)
(Table 3).
Serum OT Levels and OXTR SNP
rs2254298 Genotypes
Both blood and DNA samples were available for 55 ASD
subjects and 110 TD controls. A Kruskal-Wallis H test detected
differences among the three genotypes in the ASD group (χ2 =
6.012, df = 2, p = 0.049) (Figure 2), but a Mann-Whitney U test
with Bonferroni correction identified no evidence for significant
associations between AA and AG genotypes (p= 0.080), AA and
GG genotypes (p= 0.095), as well as AG and GG genotypes (p=
1.000).
Correlations between Serum OT Levels
and ASD Social Phenotypes
ABC scores and CARS scores were only determined for ASD
subjects. Spearman correlation and Spearman partial correlation
FIGURE 1 | Vertical bar charts of serum oxytocin levels across
diagnosis (ASD compared with TD) and genders (males compared with
females) with median (IQR). Error bars show interquartile range (IQR).
Group: n = 55 ASD and n = 110 TD. Male: n = 43 ASD and n = 86 TD.
Female: n = 12 ASD and n = 24 TD. The ASD group exhibited significantly
higher serum oxytocin levels than the TD group.*p < 0.05. ASD, autism
spectrum disorders; IQR, interquartile range; TD, typically developing.
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TABLE 2 | Correlations between serum OT levels and age, as well as IQ in
ASD and TD groups.
Group Spearman correlation Spearman partial correlation
Serum OT levels Confounding
factors
Serum OT levels
r p r p
ASD-AGE
Total (n = 55) 0.270 0.046 sex + IQ 0.202 0.147
Male (n = 43) 0.349 0.022 IQ 0.263 0.093
Female (n = 12) −0.098 0.761 IQ −0.050 0.883
TD-AGE
Total (n = 110) −0.085 0.377 sex + IQ −0.079 0.417
Male (n = 86) −0.086 0.430 IQ −0.078 0.478
Female (n = 24) −0.160 0.455 IQ −0.138 0.529
ASD-IQ
Total (n = 55) −0.216 0.113 sex + age −0.078 0.577
Male (n = 43) −0.256 0.097 age −0.099 0.532
Female (n = 12) 0.109 0.736 age 0.069 0.841
TD-IQ
Total (n = 110) −0.154 0.108 sex + age −0.123 0.204
Male (n = 86) −0.049 0.656 age −0.032 0.772
Female (n = 24) −0.312 0.078 age −0.323 0.106
Spearman partial correlation: adjusted for confounding factors in the table. ASD, autism
spectrum disorders; IQ, intelligent quotient; n, number; OT, oxytocin; TD, typically
developing. The bold value means significant p.
TABLE 3 | Participant genotypic and allelic frequencies of the OXTR SNP
rs2254298 by group.
Group Genotype Allele
AA AG GG A G
ASD subjects 14 (14.0%) 42 (42.0%) 44 (44.0%) 70 (35.0%) 130 (65.0%)
TD controls 24 (10.3%) 100 (43.1%) 108 (46.6%) 148 (31.9%) 316 (68.1%)
χ
2 0.935 0.610
df 2 1
p 0.627 0.435
ASD, autism spectrum disorders; TD, typically developing.
(adjusted for sex, age, and IQ) were both applied for all
scores of the ABC and CARS. We found a significant positive
correlation between serum OT levels and CARS total scores
(Spearman correlation: r = 0.488, p = 0.000; Spearman partial
correlation: r = 0.465, p = 0.001), suggestive of more social
deficits with high serum OT levels. Moreover, serum OT
levels also correlated positively with the “adaptation to change
score” in the CARS (Spearman correlation: r = 0.352, p =
0.008; Spearman partial correlation: r = 0.296, p = 0.033),
indicating that ASD subjects with higher serum OT levels
were accompanied by worse abilities in adapting to novel
environment. There were no significant corrections between
serum OT levels and scores of other items in the CARS
and ABC.
FIGURE 2 | Vertical bar charts of serum oxytocin levels for the three
OXTR SNP rs2254298 genotypes in both ASD and TD groups are
presented as median (IQR). Error bars show interquartile range (IQR). ASD
group: n = 9 AA, n = 21 AG, and n = 25 GG. TD group: n = 9 AA, n = 52 AG,
and n = 49 GG. The ASD subjects exhibited a significant association between
serum oxytocin levels and three OXTR SNP rs2254298 genotypes, and serum
oxytocin levels were low in ASD subjects with an AA genotype. *p < 0.05.
ASD, autism spectrum disorders; IQR, interquartile range; OXTR, oxytocin
receptor; SNP, single-nucleotide polymorphism; TD, typically developing.
OXTR SNP rs2254298 Genotypes and ASD
Social Phenotypes
All scores for the 5 ABC categories conformed to a normal
distribution and homogeneity of variance (p > 0.05) in two
groups, including “ASD subjects for both OT and OXTR” (n =
55) and “ASD subjects for OXTR” (n = 100). In both groups,
a one-way covariance (ANCOVA) with sex, age, and IQ as
covariates indicated a significant relationship between genotypes
and the “stereotypes and object use score” of the ABC [F(2, 52)
= 5.178, p = 0.006, n = 55; F(2, 97) = 11.022, p = 0.000, n =
100]. Further the Bonferroni post-hoc test revealed significant
differences between the AA and AG genotypes in both ASD
groups with different sample sizes (“ASD subjects for both OT
and OXTR” group: p = 0.005, n = 30; “ASD subjects for OXTR”
group: p = 0.000, n = 56) as well as between the AA and GG
genotypes in “ASD subjects forOXTR” group (p= 0.001, n= 58)
(Figure 3). The score of subjects with an AA genotype was higher
than that of subjects with AG or GG genotypes, indicating that
the participants with an AA genotype exhibited worse behavioral
deficits in stereotyped behavior and impaired ability of using
objects.
A Kruskal-Wallis H test followed by Bonferroni-corrected
Mann-Whitney U test was applied to make the comparisons
of CARS total scores among three genotypes of OXTR SNP
rs2254298, but no differences were found (p > 0.05). Moreover,
a ordinal polytomous logistic regression analysis with post-hoc
Bonferroni correction was used to analyze differences of scores of
each item in the CARS among OXTR SNP rs2254298 genotypes
(while adjusting for sex, age, and IQ). Significant associations of
“adaptation to change score” in the CARS among three genotypes
were found in ASD subjects. ORs (95% CI) for “4 = severely
abnormal” of “adaptation to change” among three OXTR SNP
rs2254298 genotypes in “ASD subjects for both OT and OXTR”
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FIGURE 3 | Vertical bar charts of ABC subscale score among the three OXTR SNP rs2254298 genotypes are presented as mean ± SEM (adjusted for
sex, age and IQ) in two groups. Error bars show standard error of the mean (SEM). Group1 (ASD subjects for both OXT and OXTR): n = 9 AA, n = 21 AG, and n =
25 GG. Group 2 (ASD subjects for OXTR): n = 14 AA, n = 42 AG, and n = 44 GG. ASD subjects with an AA genotype exhibited a higher score than those with an AG
genotype or a GG genotype. *p < 0.05. **p < 0.01. ABC, Autism Behavior Checklist; ASD, autism spectrum disorders; OXT, oxytocin; OXTR, oxytocin receptor; SEM,
standard error of the mean; SNP, single-nucleotide polymorphism.
(n = 55) and “ASD subjects for OXTR” (n = 100) groups were
shown in Table 4. ASD subjects with an AA genotype acted
as a protective genotype for suffering from the most severe
abnormality of “adaptation to change,” indicating that ASD
subjects with AG and GG genotypes tended to perform worse
social cognition in novel environment.
DISCUSSION
Animal and human studies, including studies of individuals with
ASD, have provided evidence for the essential role of OT and the
OXTR gene in social functioning. In the present study, we tested
serum OT levels of both genders and elevated serum OT levels
were observed in the ASD group compared to the TD group.
Serum OT levels correlated positively with the “adaptation to
change score” and “total scores” of the CARS. No associations
were found between serum OT levels and age, as well as IQ in
both ASD and TD groups. In addition, we made a comparison of
theOXTR rs2254298 polymorphism in both groups and observed
no statistical significance. However, significant associations were
detected betweenOXTR SNP rs2254298 genotypes and serumOT
levels, the “stereotypes and object use score” of the ABC and the
“adaptation to change score” of the CARS in the ASD subjects.
Our finding of higher serum OT levels in ASD participants
was similar to several previous studies on plasma OT levels in
individuals with ASD. For example, Jansen et al. (2006) observed
increased plasma OT levels in a group of male and female ASD
adults, and explained that developmental, intellectual, or other
factors as well as a physiological reaction on negative moods
and stress may relate to the higher OT plasma levels in ASD
participants. Thus far, evidence has suggested elevated peripheral
OT levels in humans and animals in connection with depression,
anxiety and social stress (Grippo et al., 2007; Holt-Lunstad et al.,
2011; Miller et al., 2013; Weisman et al., 2013) as well as a
relationship betweenOT levels and altered energetic stress coping
approaches and anxiolytic influences (Insel, 2010; Neumann
and Landgraf, 2012; Lukas and Neumann, 2013). Exposure
to unfamiliar environments is well-known to be stressful for
individuals with ASD, which can trigger a stress response to
release central OT to counter negative emotions (Gimpl and
Fahrenholz, 2001). We could not find the correlations between
serum OT levels and age in the ASD group (including males
and females) after adjusting for IQ, which predicted that the
intellectual factors might be restrictive factors for serum OT
levels and developmental stage. However, we detected higher
serum OT levels were associated with worse ability in adapting
to change and greater social deficits (as evidenced by high
CARS total scores) in ASD subjects, predicting impairments
in social functioning may lead them to release more OT to
withstand different novel environments. Furthermore, Jacobson
et al. (2014) reported that prepubertal male children with ASD
exhibit elevated plasma OT levels and increased G protein
subunit expression relative to TD controls and higher oxytocin
levels associated with greater social impairment. We conjectured
that a dysregulation in OT signaling pathways likely including
a potential compensatory mechanism for the changes of OXTR
gene expression may also lead to elevated OT levels in ASD
subjects. That is why we designed experiments on both serum
OT levels and an OXTR gene polymorphism to find latent
disturbances in ASD individuals.
However, Miller et al. (2013) reported that girls exhibit higher
plasma OT levels and elevated anxiety scores than boys within
an autistic group instead of the difference between the cases and
controls. Similarly, Taurines et al. (2014) also did not observe
differences in plasma OT levels of children and adolescents
between high-functioning male ASD subjects and healthy male
controls, nor did Parker et al. (2014) among ASD participants,
unaffected siblings and unrelated neurotypical control children
of both genders. Moreover, four studies have exhibited lower
plasma OT levels. Modahl et al. (1998) reported lower plasma OT
levels in prepubertal boys with ASD relative to TD boys, but ASD
participants with the highest OT levels were the most socially
impaired. Moreover, they found a positive association between
OT levels and age for normal children, which was opposite
from our finding. Green et al. (2001) observed a decrease in
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TABLE 4 | Odds ratios (ORs) with 95% confidence intervals (CI) of having severe abnormality of 15 items in the CARS among three OXTR SNP rs2254298
genotypes in two ASD groups.
Items of CARS Ref ASD subjects for both OT and OXTR (n = 55) ASD subjects for OXTR (n = 100)
AA vs. AG AA vs. GG AG vs. GG AA vs. AG AA vs. GG AG vs. GG
Relating to people 4 2.34 (0.34, 16.02) 1.33 (0.41, 4.30) 0.57 (0.22, 1.47) 0.75 (0.19, 3.04) 0.73 (0.30, 1.77) 0.97 (0.51, 1.84)
Imitative behavior 4 0.91 (0.16, 5.31) 0.91 (0.30, 2.72) 0.99 (0.43, 2.29) 0.47 (0.12, 1.84) 0.63 (0.27, 1.49) 1.33 (0.72, 2.44)
Emotional response 4 0.29 (0.03, 2.81) 0.39 (0.09, 1.66) 1.37 (0.49, 3.79) 0.70 (0.19, 2.64) 0.60 (0.26, 1.39) 0.85 (0.46, 1.57)
Body use 4 1.15 (0.19, 6.88) 1.09 (0.36, 3.32) 0.95 (0.41, 2.20) 1.60 (0.45, 5.72) 1.13 (0.51, 2.52) 0.71 (0.39, 1.28)
Object use 4 0.84 (0.13, 5.49) 0.83 (0.26, 2.69) 0.99 (0.41, 2.38) 0.27 (0.07, 1.07) 0.60 (0.15, 1.06) 0.71 (0.39, 1.28)
Adaptation to change 4 0.07 (0.01, 0.50)** 0.22 (0.07, 0.77)* 3.24 (1.36, 7.69)** 0.12 (0.03, 0.45)** 0.30 (0.13, 0.71)** 2.60 (1.43, 4.73)**
Visual response 4 1.03 (0.17, 6.37) 1.09 (0.35, 3.41) 1.05 (0.44, 2.50) 1.70 (0.48, 6.01) 1.29 (0.58, 2.85) 0.761 (0.42, 1.37)
Listening response 4 1.46 (0.29, 7.39) 1.17 (0.43, 3.20) 0.80 (0.37, 1.72) 2.45 (0.74, 8.05) 1.76 (0.83, 3.71) 0.72 (0.42, 1.24)
Perceptive response 4 1.04 (0.19, 5.64) 0.72 (0.25, 2.06) 0.69 (0.31, 1.55) 0.92 (0.28, 3.02) 0.79 (0.38, 1.68) 0.86 (0.50, 1.50)
Fear or anxiety 4 0.60 (0.11, 3.30) 0.76 (0.26, 2.17) 1.26 (0.56, 2.84) 0.43 (0.13, 1.47) 0.58 (0.27, 1.26) 1.34 (0.76, 2.34)
Verbal communication 4 0.43 (0.07, 2.75) 0.61 (0.19, 1.91) 1.40 (0.59, 3.33) 0.43 (0.11, 1.63) 0.55 (0.24, 1.27) 1.27 (0.69, 2.32)
Non-verbal communication 4 0.60 (0.10, 3.48) 0.70 (0.24, 2.10) 1.18 (0.51, 2.69) 0.90 (0.25, 3.23) 0.96 (0.43, 2.14) 1.07 (0.59, 1.92)
Activity level 4 0 (0, 3.24E+160) 0 (0, 8.43E+106) 29.37 (0, 3.32E+56) 0.16 (0.02, 1.62) 0.26 (0.06, 1.18) 1.63 (0.66, 4.02)
Level and consistency of
intellective relation
4 0.72 (0, 1.25E+36) 0.91 (0, 1.54E+24) 1.27 (0, 2.59E+12) 5.36 (0, 1.34E+43) 3.37 (0, 6.04E+28) 0.63 (0, 9.46E+13)
General impressions 4 2.44 (0.30, 19.59) 1.66 (0.46, 6.00) 0.68 (0.25, 1.82) 1.75 (0.39, 7.88) 1.21 (0.47, 3.11) 0.69 (0.35, 1.38)
Rating of 15 items in CARS with a four-point scale (1 = appropriate for age; 2 = mildly abnormal; 3 = moderately abnormal; 4 = severely abnormal). The reference (Ref) rating is 4 in a
ordinal polytomous logistic regression analysis. ASD subjects for both OXT and OXTR: n = 9 AA, n = 21 AG, and n = 25 GG. ASD subjects for OXTR: n = 14 AA, n = 42 AG, and n =
44 GG. *p < 0.05; **p < 0.01. ASD, autism spectrum disorders; CARS, Childhood Autism Rating Scale; n, number; OT, oxytocin; OXTR, oxytocin receptor; Ref, reference; vs, versus.
OT and an increase in unprocessed OT peptides in male autistic
children, relative to controls. Andari et al. (2010) elucidated
lower plasma OT levels in young adults with high-functioning
autism (HFA) or Asperger Syndrome, and Al-Ayadhi (2005)
reported lower plasma levels of OT in children and adolescents
with ASD.
Overall, a substantial body of research has reported
inconsistent outcomes in peripheral OT levels, which could
be the result of differences among participants and investigative
methods, including the multiple demographic characteristics
of the ASD population (age, gender, intelligence, ethnicity,
comorbidity, medication history, sample size, diagnostic criteria,
etc.), the blood sample collection time and the measurement
and analysis of OT levels. Decreased OT levels in ASD might
be a manifestation of the original genetic insult of ASD, and
elevated OT levels in ASD might reflect a physiological response
to ameliorate negative symptoms such as anxiety (Taurines et al.,
2014) and be consistent with some degree of a dysregulation in
OT peptide processing pathways (Green et al., 2001). Because
plasma OT concentrations are highly heritable (Parker et al.,
2014), family effects should be taken into consideration in
subsequent studies.
With the aim of establishing the role of the OXTR gene
in ASD, we chose to study a particularly promising candidate:
OXTR SNP rs2254298. Many studies have reported that OXTR
SNP rs2254298 affects various psychological dimensions and
neurological diseases, such as affect, temperament, genetic
variation, attachment and social cognition. However, there
is extant literature failing to associate the OXTR rs2254298
polymorphism with ASD consistently.
The first association study examining 4 SNPs in 195 Chinese
Han autism trios with a family-based association test (FBAT)
revealed a significant genetic association with rs2254298A and
rs53576A (Wu et al., 2005). A Japanese study only observed
a significant difference in rs2254298A between the ASD and
normal groups in a population-based case-control test but
not in an FBAT (Liu et al., 2010). A study of 57 American
Caucasians attempted to replicate the Asian studies but only
detected an association with rs2254298G (Jacob et al., 2007).
Four studies did not identify any direct associations between
the OXTR rs2254298 polymorphism and ASD. A comprehensive
study of 18 tagged SNPs across the entire OXTR gene region
in 152 Israeli autistic subjects was undertaken using HapMap
data, the Haploview algorithm, a case-control test, and a FBAT.
A five-locus haplotype block (rs237897-rs13316193-rs237889-
rs2254298-rs2268494) was significantly associated with ASD,
but SNP rs2254298 in the case-control test did not reveal any
associationwith ASD except for the relationship with “daily living
skills” and “communication” scores of the Vineland Adaptive
Behavior Scales (Lerer et al., 2008). A study in northern European
Caucasians reported the association of Asperger Syndrome
with multiple haplotypes that included rs2254298, but no
association between rs2254298 alone with Asperger Syndrome
was observed (Di Napoli et al., 2014). Another study on HFA
in Swiss Caucasians between 5 and 17 years of age confirmed
no association between rs2254298 and ASD (Nyffeler et al.,
2014); this finding was similar to the finding in a family-based
single-marker and haplotype association study with 22 SNPs in
100 German families with a high-functioning autistic proband
(Wermter et al., 2010).
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Our study did not detect any association between rs2254298
and ASD, which was similar to the conclusion of a meta-
analysis: a solid role in autism has not been established for
OXTR rs2254298 (Bakermans-Kranenburg and van Ijzendoorn,
2014). However, after the analyses of the genotypes among
serum OT levels and the scores for ABC and CARS, some
interesting associations were detected in the present study. A
significant association between serum OT levels and OXTR
rs2254298 polymorphism was observed in the ASD group, and
the serum OT levels of an AA genotype showed the potential
to be lower than the AG and GG genotypes, which suggested
that a dysfunction of OXTR SNP rs2254298 in ASD subjects may
somewhat impact OT levels in OXTR-OT signaling pathways.
The score for “stereotypes and object use” in the ABC revealed
significant differences among the three genotypes in two groups
with different sample sizes. The severity of behavioral deficits in
ASD participants with an AA genotype was significantly greater
than the AG genotype in “ASD subjects for both OT and OXTR”
(n = 55) group, and the severity of behavioral deficits in ASD
participants with an AA genotype was significantly greater than
the AG and GG genotypes in “ASD subjects forOXTR” (n= 100)
group. Although no evidence for a direct association between
serum OT levels and “stereotypes and object use score,” we found
ASD subjects with AG and GG genotypes tend to have higher
OT levels and lesser behavioral impairments (including restricted
and repetitive behaviors). These results appeared to be consistent
with the reduced repetitive behaviors after intranasal OT infusion
(Hollander et al., 2003). Furthermore, the score of “adaptation to
change” in the CARS was also found to be statistically significant
in two groups with different sample sizes, and ASD subjects
with an AA genotype were better able to adapt to change than
those with AG and GG genotypes. Along with a significant
correction between serum OT levels and “adaptation to change
score,” we also found ASD subjects with an AA genotype tend
to show lower OT levels and lesser social cognitive impairment
compared to those with AG and GG genotypes. This result might
stem from the different reactions to different novel environments
along with different severity of social cognitive deficits (Tops
et al., 2013). Above all, we found the ASD subjects with an
AA genotype have the better ability to adapt to change, as a
result, they might produce less OT to deal with different novel
environments. However, elevated OT levels can reduce repetitive
behaviors in ASD patients (Hollander et al., 2003), and this may
be the reason for higher score of “stereotypes and object use” in
ASD subjects with an AA genotype. On the whole, we speculate
that differences in serum OT levels and social deficits among
OXTR SNP rs2254298 genotypes likely involve changes at the
OXTR expression as well as environmentally induced alterations
of the basal oxytocinergic system in ASD.
The first strength of our study lies in the combination of the
OXTR rs2254298 polymorphism with serum OT levels in both
ASD and TD groups as well as the effect of the OXTR SNP
rs2254298 on ASD social phenotypes. Our results could to some
extent explain the potential role of OT in the impairment of
social and behavioral skills in ASD (Bartz and Hollander, 2008)
and provide ideas to explain the opposite emotion recognition
performance after OT administration between different OXTR
haplotypes (Chen et al., 2015). Secondly, both age- and gender-
matched males and females participated in the study, which
extended the findings of most previous studies that involved
only males. Thirdly, a standardized protocol for blood and DNA
collection with fasting in the morning was used to preclude
potential circadian and contaminating effects on serumOT levels
and DNA quality.
There are three limitations of our study. First, we chose
serum rather than CSF as the test sample, and serum OT levels
can not completely reflect OT actions in the central nervous
system because the relationship between peripheral and central
levels of OT is unclear. Second, we only got informed consent
from 55 ASD subjects and 110 TD controls to measure both
serum OT levels and the OXTR rs2254298 polymorphism, which
needs to expand the sample size in further studies. Finally, the
PLINK program was not performed in our study, we had to
calculate the allele frequencies by hand and then do case-control
association analysis by a χ2-test using SPSS. Our findings will
need to be replicated in East Asian samples and very large samples
will be required to examine these associations in European
samples.
In summary, to the best of our knowledge, our study
is the first to test serum OT levels in ASD participants
and analyze the association between the OXTR rs2254298
polymorphism and serum OT levels, the ABC scores and the
CARS scores. ASD subjects exhibited elevated serum OT levels
and a latent association among OT levels, the OXTR rs2254298
polymorphism and ASD social deficits existed in ASD group.
Although we did not detect any direct association between the
OXTR rs2254298 polymorphism and ASD, between serum OT
levels and age, as well as and between serum OT levels and
IQ, we could indentify some clues to indicate social deficits
in ASD individuals with OT levels and the OXTR rs2254298
polymorphism. Subsequent prospective studies should focus on
larger, well-described populations of different races to elucidate
the true effects of the OT and OXTR gene on ASD under
the considerations of genetic, environmental and developmental
factors, then design a reasonable therapeutic schedule for the
oxytocinergic system to improve their social deficits.
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